Jump to Content
Photo of Hodgson Russ Assists UMES In Securing U.S. Patent For Epilepsy Drug
News

Hodgson Russ Assists UMES In Securing U.S. Patent For Epilepsy Drug

May 9, 2018

The Hodgson Russ Intellectual Property & Technology Team has successfully assisted the University of Maryland Eastern Shore (UMES) in obtaining a U.S. Patent for a chemical formula treatment for epilepsy. The medical research project that led to this discovery was spearheaded by Dr. Patrice Jackson-Ayotunde, Ph.D., an Associate Professor of Pharmaceutical Sciences at UMES. 65 million people suffer from epilepsy and one in 26 Americans will be diagnosed at some point in their lifetime. Dr. Jackson-Ayotunde focused her research regarding the design and synthesis of novel anticonvulsant analogs as potential agents for treatment of therapy-resistant partial epilepsy. Read the official UMES press release on the patent here: https://www.umes.edu/PR/News-Articles/2018/New-epilepsy-treatment-idea-emerges-at-UMES/